IA
OLMA icon

IndexIQ Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

IndexIQ Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$387K Buy
+90,750
New +$500K 0.01% 863

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

IndexIQ Advisors's OLMA Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2022: 90,750 shares worth $387K. The stake represents 0.01% of the portfolio and ranks #863 among its holdings.

91 funds tracked by Wall St. Rank hold OLMA as of Q1 2022.

  • IndexIQ Advisors held 90,750 shares of Olema Pharmaceuticals worth $387K as of Q1 2022.
  • Olema Pharmaceuticals was a new IndexIQ Advisors position in Q1 2022.
  • Olema Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #863 holding.
  • 91 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.